Literature DB >> 21327027

Proinflammatory fecal mRNA and childhood bacterial enteric infections.

William E Bennett1, Rosbel González-Rivera, Bao N Puente, Nurmohammad Shaikh, Harold J Stevens, Jody C Mooney, Eileen J Klein, Donna M Denno, Andrew Draghi, Francisco A Sylvester, Phillip I Tarr.   

Abstract

INTRODUCTION: Assessment of specific mRNAs in human samples is useful in characterizing disease. However, mRNA in human stool has been understudied.
RESULTS: Compared to controls, infected stools showed increased transcripts of IL-1β, IL-8 and calprotectin. mRNA and protein concentrations correlated for IL-8, but not for calprotectin. DISCUSSION: Stool mRNA quantification offers a potentially useful, noninvasive way to assess inflammation in the gastrointestinal tract, and may be more sensitive than EIA.
METHODS: We purified fecal RNA from 46 children infected with Campylobacter jejuni, Escherichia coli O157:H7, Salmonella spp. or Shigella sonnei and 26 controls and compared the proportions of IL-1β, IL-8, osteoprotegerin and calprotectin mRNA between groups using qRT-PCR. We determined the concentrations of calprotectin, IL-8 and osteoprotegerin by enzyme immunoassays in cognate specimens.

Entities:  

Year:  2010        PMID: 21327027      PMCID: PMC3023602          DOI: 10.4161/gmic.1.4.13004

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  15 in total

Review 1.  The peripheral-blood transcriptome: new insights into disease and risk assessment.

Authors:  Steve Mohr; Choong-Chin Liew
Journal:  Trends Mol Med       Date:  2007-10-04       Impact factor: 11.951

Review 2.  Integrating global gene expression analysis and genetics.

Authors:  Charles R Farber; Aldons J Lusis
Journal:  Adv Genet       Date:  2008       Impact factor: 1.944

3.  An efficient RNA extraction method for estimating gut microbial diversity by polymerase chain reaction.

Authors:  Seungha Kang; Stuart E Denman; Mark Morrison; Zhongtang Yu; Chris S McSweeney
Journal:  Curr Microbiol       Date:  2009-01-22       Impact factor: 2.188

4.  Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.

Authors:  Jennifer Jones; Edward V Loftus; Remo Panaccione; Li-Sheng Chen; Sandra Peterson; Joseph McConnell; Linnea Baudhuin; Karen Hanson; Brian G Feagan; Scott W Harmsen; Alan R Zinsmeister; Emelie Helou; William J Sandborn
Journal:  Clin Gastroenterol Hepatol       Date:  2008-09-17       Impact factor: 11.382

5.  A method for isolating and analyzing human mRNA from newborn stool.

Authors:  William E Bennett; Rosbel González-Rivera; Nurmohammad Shaikh; Vincent Magrini; Michelle Boykin; Barbara B Warner; Aaron Hamvas; Phillip I Tarr
Journal:  J Immunol Methods       Date:  2009-08-03       Impact factor: 2.303

6.  Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity.

Authors:  David E Greenberg; Zhi-Dong Jiang; Robert Steffen; Mangala P Verenker; Herbert L DuPont
Journal:  J Infect Dis       Date:  2002-03-19       Impact factor: 5.226

Review 7.  Predictive biomarkers and signatures in urinary bladder cancer.

Authors:  Peter H Roos; Klaus Golka; Jan G Hengstler
Journal:  Curr Opin Mol Ther       Date:  2008-06

8.  Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis.

Authors:  C G B Peterson; P Sangfelt; M Wagner; T Hansson; H Lettesjö; M Carlson
Journal:  Scand J Clin Lab Invest       Date:  2007       Impact factor: 1.713

9.  Cytokines in the stools of children with complicated shigellosis.

Authors:  T Azim; R C Halder; M S Sarker; S Ahmed; J Hamadani; A Chowdhury; F Qadri; M A Salam; R B Sack; M J Albert
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

10.  Escherichia coli O157:H7 infections: discordance between filterable fecal shiga toxin and disease outcome.

Authors:  Nancy A Cornick; Srdjan Jelacic; Marcia A Ciol; Phillip I Tarr
Journal:  J Infect Dis       Date:  2002-06-10       Impact factor: 5.226

View more
  5 in total

1.  MAPK-activated protein kinase 2 contributes to Clostridium difficile-associated inflammation.

Authors:  Linda D Bobo; Rana E El Feghaly; Yee-Shiuan Chen; Erik R Dubberke; Zhuolin Han; Alexandra H Baker; Jinmei Li; Carey-Ann D Burnham; David B Haslam
Journal:  Infect Immun       Date:  2012-12-21       Impact factor: 3.441

2.  The Bacterial Species Campylobacter jejuni Induce Diverse Innate Immune Responses in Human and Avian Intestinal Epithelial Cells.

Authors:  Daniel A John; Lisa K Williams; Venkateswarlu Kanamarlapudi; Thomas J Humphrey; Thomas S Wilkinson
Journal:  Front Microbiol       Date:  2017-09-29       Impact factor: 5.640

3.  Mucosal Immune Profiles Associated with Diarrheal Disease Severity in Shigella- and Enteropathogenic Escherichia coli-Infected Children Enrolled in the Global Enteric Multicenter Study.

Authors:  Amanda D Buskirk; Esther Ndungo; Avital A Shimanovich; Diana Lam; William C Blackwelder; Usman N Ikumapayi; Bing Ma; Helen Powell; Martin Antonio; James P Nataro; James B Kaper; Marcela F Pasetti
Journal:  mBio       Date:  2022-08-04       Impact factor: 7.786

4.  Droplet digital PCR quantifies host inflammatory transcripts in feces reliably and reproducibly.

Authors:  Jennifer Stauber; Nurmohammad Shaikh; M Isabel Ordiz; Phillip I Tarr; Mark J Manary
Journal:  Cell Immunol       Date:  2016-04-06       Impact factor: 4.868

5.  Environmental Enteric Dysfunction Includes a Broad Spectrum of Inflammatory Responses and Epithelial Repair Processes.

Authors:  Jinsheng Yu; M Isabel Ordiz; Jennifer Stauber; Nurmohammad Shaikh; Indi Trehan; Erica Barnell; Richard D Head; Ken Maleta; Phillip I Tarr; Mark J Manary
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-12-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.